[1] Navarro VJ,Senior JR. Drug-related hepatotoxicity. N Engl J Med,2006,354(7):731-739. [2] 茅益民,曾民德. 药物性肝损伤的诊断. 药物评价,2007,4(6):389. [3] 王凡,刘宾,李莉,等. 急性药物性肝损害的临床分析和治疗探讨. 中国医院用药评价与分析,2007,79(3):193-195. [4] 许彪,何卫平,张爱民,等. 两种国际诊断标准对 230例药物性肝损害诊断的分析比较. 中华肝脏病杂志,2007,15(12):926-929. [5] Benichou C.Criteria of drug-induced liver disorders.Report of an international consensus meeting. J Hepatol,1990,11(2):272-276. [6] 朱斌,章福彬,刘卫,等. 药物性肝损害 88 例临床分析. 实用肝脏病杂志,2008,11(6):396-397. [7] 张涛,贾继东. 107例药物性肝损害的病因和临床特点.肝脏,2005,10:174-176. [8] 刘冬梅.中药及其制剂临床应用安全问题的分析. 中国现代药物应用. 2010,4(13):115-116. [9] 鄢良春,赵军宁,邱雄. 何首乌安全性问题研究进展. 中药药理与临床,2009,25(3):77-80,449. [10] 徐英,陈崇崇,杨莉,等. 基于胆汁酸代谢网络分析中药黄药子的肝毒性. 药学学报,2011,46(1):39-44. [11] 柴智,周文静,高丽. 雷公藤肝毒性及其作用机制的研究进展.中国实验方剂学杂志,2011,17(7):243-246. [12] 李玥,徐立,刘若囡,等. 生、制首乌醇提物对小鼠肝脏的影响.海南医学院学报,2011,17(4):452-455. [13] 戴维佳,赖荣陶,王晖. 113例药物性肝损害临床特征及影响因素分析. 临床肝胆病杂志,2011,27(10):1058-1065. [14] Wysowski DK,Fourcroy JL. Flutamide hepatotoxicity. J Urol,1996,155(1):209-212. [15] Andrade RJ,Robles M,Ulzurrun E,et al. Drug-induced liver injury:insights from genetic studies.Pharmacogenomics,2009,10(9):1467-1487. [16] Han D,Dara L,Win S,et al. Regulation of drug-induced liver injury by signal transduction pathways:critical role of mitochondria.Trends Pharmacol Sci,2013,34(4):243-253. [17] Lee WM. Drug-induced hepatotoxicity. N Engl J Med,1995,333(17):1118-1127. [18] Luo L,Schomaker S,Houle C,et al. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents. Toxicol Sci,2014,137(1):12-25. [19] Shi Q,Hong H,Senior J,et al. Biomarkers for drug-induced liver injury. Expert Rev Gastroenterol Hepatol,2010,4(2):225-234. [20] Shi Q,Yang X,Mendrick DL. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury. Biomark Med,2013,7(2):307-315. |